GlassScriptPhysician profile
Sergio Gaitan
NPI 1386087583
$3,050.42
in general payments reported to CMS, 2019-2025
24 companies · $256 in 2025
The $256 reported for 2025 was less than what a typical Dermatology provider received nationally (typical 2025 total: $772).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $448 · 2020: $79.39 · 2021: $341 · 2022: $1,022 · 2023: $349 · 2024: $556 · 2025: $256.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,161.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,160.91 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Allergan, INC. | $738.20 | 2019-2022 | |
| Abbvie INC. | $462.90 | 2022-2025 | |
| Galderma Laboratories, L.P. | $380.58 | 2021-2024 | |
| Leo Pharma INC. | $262.14 | 2019-2022 | |
| Merz North America, INC. | $184.31 | 2024 | |
| Pfizer INC. | $163.56 | 2019-2022 | |
| Abbott Laboratories | $135.08 | 2025 | Freestyle Libre 3 |
| Novartis Pharmaceuticals Corporation | $116.15 | 2022-2023 | |
| Regeneron Healthcare Solutions, INC. | $69.97 | 2022-2023 | Dupixent |
| Vyne Pharmaceuticals INC. | $69.48 | 2020-2021 | |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $65.26 | 2019-2023 | Jublia, Arazlo, Duobrii |
| Dermira, INC. | $64.47 | 2019 | |
| Journey Medical Corporation | $60.95 | 2020-2022 | |
| Sun Pharmaceutical Industries INC. | $52.16 | 2021-2022 | |
| Revance Therapeutics, INC. | $43.60 | 2024 | Daxxify |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Mayne Pharma Commercial LLC | $24.41 | 2022-2023 | |
| Aclaris Therapeutics, INC. | $24.13 | 2019 | |
| Arcutis Biotherapeutics, INC. | $23.66 | 2023 | |
| Verrica Pharmaceuticals INC. | $23.24 | 2023 | Ycanth |
| Almirall LLC | $23.20 | 2022 | |
| Organogenesis INC. | $18.09 | 2021 | |
| Redhill Biopharma INC. | $17.34 | 2021 | |
| Epi Health, LLC | $14.39 | 2021 | |
| Strata Skin Sciences, INC. | $13.15 | 2023 | Xtrac |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sergio Gaitan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.